HiroshiMiyamotoMD

Anatomic Pathology

Associate Professor of Pathology, Associate Professor of Urology, Johns Hopkins University School of Medicine

Are you Dr. Miyamoto?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting!
Read the latest clinical news, personalized to your specialty.

Office
601 Elmwood Ave
# 320
Rochester, NY 14642
Phone+1 585-275-8748

Fax+1 585-273-3637

Dr. Hiroshi Miyamoto, MD is a board certified pathologist in Rochester, New York. He is currently licensed to practice medicine in New York and Maryland. He is affiliated with Strong Memorial Hospital of the University of Rochester and F. F. Thompson Hospital.

PubMed

16 citations
Curative-Intent Surgery for Stage IV Advanced Gastric Cancer: Who Can Undergo Surgery and What Are the Prognostic Factors for Long-Term Survival?
Sho Sato, Chikara Kunisaki, Yusaku Tanaka, Kei Sato, Hiroshi Miyamoto
Annals of Surgical Oncology. 2019-09-16
45 citations
Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer.
Christopher Silvers, Yu Ru Liu, Chia Hao Wu, Hiroshi Miyamoto, Edward M. Messing
Oncotarget. 2016-03-10
89 citations
Decreased Tumorigenesis and Mortality from Bladder Cancer in Mice Lacking Urothelial Androgen Receptor
Jong-Wei Hsu, Iawen Hsu, Defeng Xu, Hiroshi Miyamoto, Liang Liang
The American Journal of Pathology. 2013-05-01

Time-Dependent Efficacy of Combination of Silver-Containing Hydroxyapatite Coating and Vancomycin on Methicillin-Resistant Staphylococcus Aureus Biofilm Formation in VitroMarch 2nd, 2021
Effects of α1-Adrenergic Receptor Antagonists on the Development and Progression of Urothelial CancerDecember 1st, 2020
Enhanced Metastatic Potential in the MB49 Urothelial Carcinoma ModelMay 15th, 2019